{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-021692","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2021-08-31T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.998207+00:00","generated_at":"2026-06-29T06:38:52.718747+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Interpace extends maturity on $7.5M notes from Ampersand and 1315 Capital to Sep 30, 2021","bullets":["Maturity of $4.5M Ampersand Note and $3.0M 1315 Capital Note extended to September 30, 2021.","Third amendments executed August 31, 2021; all other terms unchanged.","Notes held by related parties that collectively own ~65.3% of common stock on as-converted basis.","Security Agreement remains in full force and effect."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-021692","json":"https://secwatch.observer/filing/0001493152-21-021692.json","markdown":"https://secwatch.observer/filing/0001493152-21-021692.md","text":"https://secwatch.observer/filing/0001493152-21-021692.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315221021692/0001493152-21-021692-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315221021692/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T06:38:52.718747+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}